| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.78B | +33.5% |
| Cost of Revenue | $1.12B | +33.3% |
| Gross Profit | $1.66B | +33.6% |
| R&D Expense | $684.3M | +55.0% |
| SG&A Expense | $1.04B | +39.8% |
| Operating Income | -$62.1M | -206.0% |
| Pre-tax Income | $19.0M | -95.0% |
| Income Tax | -$105.7M | -2464.3% |
| Net Income | $124.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.20B | +164.1% |
| Short-term Investments | $505.4M | +51.7% |
| Inventory | $341.8M | +28.8% |
| Current Assets | $3.71B | +61.6% |
| Total Assets | $7.00B | +56.4% |
| Current Liabilities | $1.47B | +47.4% |
| Long-term Debt | $1.81B | +166.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $211.3M | -48.2% |
| Capital Expenditures | $136.3M | +72.9% |
| Investing Cash Flow | -$724.9M | -47.8% |
| Financing Cash Flow | $1.25B | +2856.5% |
| Free Cash Flow | $75.1M | -77.2% |
| -66.9% |
| EPS (Basic) | $1.60 | -67.9% |
| EPS (Diluted) | $1.51 | -68.5% |
| Total Liabilities |
| $3.76B |
| +75.0% |
| Stockholders' Equity | $3.24B | +39.3% |